Phase 3 Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with type 2 diabetes
- People who are 18 years of age or older
- People with a body mass index (a measure of body weight relative to height) above 18.5
- People who are either not currently taking any diabetes medication, or who are only taking metformin, and who are willing to be randomly assigned to take either dapagliflozin or metformin as part of the trial
- People whose kidneys are working at a sufficient level (a kidney function score of 45 or above on a standard test called eGFR)
- People who have given their written agreement to participate in the trial
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose blood sugar levels are so high that their doctor feels they urgently need stronger diabetes treatment right away
- People for whom either metformin or a type of medication called an SGLT2 inhibitor is either clearly recommended as necessary or clearly not safe to take
- People who have a confirmed history of serious heart conditions, such as a heart attack, a procedure to open blocked heart arteries, heart bypass surgery, or heart failure that has been diagnosed by a hospital admission, a specialist, or a heart scan
- People who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bruce Neal, The George Institute for Global Health (Sydney, Australia)
Phone: +61 2 8052 4337
Australian sites
+61 2 8052 4337
+61 2 8052 4337
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Rate of decline in eGFR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.